Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 12-2022 | |
| Operating Expenses | 222 | 287 | 0 | 287 | 0 |
| Operating Income | -222 | -287 | N/A | -287 | N/A |
| Interest Expense | 12 | 16 | 0 | 15 | 0 |
| Other Income | -19 | -20 | 0 | -10 | 0 |
| Pre-tax Income | -253 | -323 | 0 | -312 | 0 |
| Net Income Continuous | -253 | -323 | N/A | -312 | N/A |
| Net Income | $-253 | $-323 | $N/A | $-312 | $N/A |
| EPS Basic Total Ops | -0.02 | -0.03 | N/A | -0.03 | N/A |
| EPS Basic Continuous Ops | -0.02 | -0.03 | N/A | -0.03 | N/A |
| EPS Diluted Total Ops | -0.02 | -0.03 | N/A | -0.03 | N/A |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | N/A | -0.03 | N/A |
| EBITDA(a) | $-143 | $-247 | $N/A | $-287 | $N/A |